During cardiac electrophysiological testing, slowed conduction upon premature ventricular activation can limit the delivery of the closely coupled impulses from the stimulation site to the region of tachycardia origin. In order to examine the contributing factors, in this study, cardiac conduction intervals and refractory periods were determined from left ventricular (LV) and the right ventricular (RV) monophasic action potential recordings obtained in perfused guinea-pig hearts. A premature activation induced immediately after the termination of the refractory period was associated with conduction slowing. The latter was primarily accounted for by the markedly increased (+54%) activation latency at the LV stimulation site, with only negligible changes (+12%) noted in the LV-to-RV delay. The prolonged activation latency was acting to limit the shortest interval at which two successive action potentials can be induced in the LV and RV chambers. The prolongation of the activation latency in premature beats was accentuated upon an increase in the stimulating current intensity, or during hypokalaemia. This change was related to the reduced ratio of the refractory period to the action potential duration, which allowed extrastimulus capture to occur earlier during phase 3 repolarization. Flecainide, a Na + channel blocker, prolonged both the activation latency and the LV-to-RV delay, without changing their relative contributions to conduction slowing. In summary, these findings suggest that the activation latency is the critical determinant of conduction slowing and associated changes in the ventricular response intervals upon extrastimulus application during phase 3 of the action potential.
INTRODUCTION
Programmed ventricular stimulation that involves a premature extrastimulus application after a train of regular pulses is widely used for testing the inducibility, entrainment and termination of cardiac arrhythmia in patients with a history of recurrent ventricular tachycardia or aborted sudden cardiac death (Josephson, Almendral, & Callans, 2014; Marchlinski et al., 1994; Wellens, Brugada, & Stevenson, 1985) . The efficacy of electrophysiological testing is importantly determined by the ability to deliver closely coupled impulses to the region of origin of the tachycardia, which ensures that the premature action potential arrives at the re-entrant circuit at a critical time (i.e. during the excitable gap) shortly after previous excitation (Liem, Mason, & Swerdlow, 1988; Mitchell, Wyse, & Duff, 1986) . Importantly, the programmed stimulation protocol is usually c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society applied at the ventricular sites remote from the arrhythmic focus.
Specifically, the right ventricular (RV) endocardium is the preferred stimulation site (Marchlinski et al., 1994; Wellens et al., 1985) , because it is easily accessible via transvenous catheterization, whereas tachycardia in most cases originates from the left ventricle (Bogun et al., 2008; Horowitz, Josephson, & Harken, 1980) , because myocardial infarction and subsequent arrhythmogenic remodelling more often occur in the left ventricular (LV) chamber.
During electrophysiological testing, a premature activation initiated prior to the full repolarization in the previous beat is associated with significant conduction slowing (Koller, Karasik, Solomon, & Franz, 1995a; Ramza, Tan, Osaka, & Joyner, 1990) , an effect that limits the shortest interval at which two successive electrical responses can be induced at the remote ventricular regions
New Findings

• What is the central question of this study?
Is the slowed conduction upon premature ventricular activations during clinical electrophysiological testing attributable to the prolonged activation latency, or increased impulse propagation time, or both?
• What is the main finding and its importance?
Prolonged activation latency at the stimulation site is the critical determinant of conduction slowing and associated changes in the ventricular response intervals in premature beats initiated during phase 3 repolarization in perfused guinea-pig heart. These relations are likely to have an effect on arrhythmia induction and termination independently of the presence of ventricular conduction defects or the proximity of the stimulation site to the reentrant circuit. (Liem et al., 1988; Mitchell et al., 1986) . It is not clear whether conduction slowing upon premature activation is primarily attributed to the prolonged stimulus-response latency, or slowed impulse propagation from the stimulation site, or both (Koller, Karasik, Solomon, & Franz, 1995b; Liem et al., 1988) . The relative importance of these factors has not been systematically addressed, because clinical electrophysiological recordings are usually limited to the RV apex (Koller et al., 1995a; Liem et al., 1988; Mitchell et al., 1986) , and the impulse propagation time at the remote myocardial regions is not assessed. Likewise, measuring the stimulus-response latency from the bipolar electrogram recordings in the right ventricle is a challenging task, because a large stimulus artifact from the adjacent stimulating electrode is usually superimposed on the initial part of the electrogram.
The purpose of the present study was to define the relative contributions of the activation latency and the impulse propagation time to the conduction slowing upon premature electrical activations induced in perfused guinea-pig hearts. The programmed stimulations were applied in the left ventricle, and cardiac conduction intervals were assessed by recording the monophasic action potentials at the adjacent (LV) and the remote (RV) epicardial sites. The activation latency and the interventricular conduction delay were measured at different coupling stimulation intervals, basic drive cycle lengths and stimulating current strengths, and upon interventions known to slow ventricular conduction, such as hypokalaemia and Na + channel blocker administration.
METHODS
Ethical approval
The present study complies with the European Community Guidelines for the Care and Use of Experimental Animals and was approved by the Animal Ethics Screening Committee of the Panum Institute (clearance no.: 2010/561-1799). Male Dunkin-Hartley guinea-pigs (Charles River, Sulzfeld, Germany) weighing 400-500 g were allowed to acclimate to the housing conditions, with free access to food and tap water, for at least 7 days prior to entry into the study. The experimental procedures used in this study comply with the policies and regulations described in the journal's guidelines for reporting animal experiments (Grundy, 2015) .
Isolated, Langendorff-perfused heart preparations
The experiments on isolated, perfused hearts were performed as described previously (Osadchii, Woodiwiss, & Norton, 2006; Soltysinska, Thiele, Olesen, & Osadchii, 2011) . The guinea-pigs were anesthetized with sodium pentobarbital (50 mg kg −1 I.P.) and anticoagulated with heparin (1000 IU kg −1 I.P.). The chest was opened, and the hearts were immediately excised, mounted on a Langendorff perfusion set-up (Hugo Sachs Elektronik/Harvard Apparatus GmbH, March-Hugstetten, Germany) and perfused via the aorta at a constant flow (15 ml min −1 ) with carefully filtered, warmed physiological saline solution saturated with 95% O 2 and 5% CO 2 . The perfusion solution contained (in mM) 118.0 NaCl, 4.7 KCl, 2.5 CaCl 2 , 25 NaHCO 3 , 1.2 KH 2 PO 4 , 1.2 MgSO 4 and 10.0 glucose, and had a pH of 7.4. In a subset of experiments with hypokalaemic perfusions, KCl concentration in the perfusion solution was decreased from 4.7 to 2.5 mM. The aortic perfusion pressure (65-70 mm Hg) was measured with an Isotec pressure transducer and the coronary flow rate was determined using an ultrasonic flowmeter probe (Transonic Systems Inc., Ithaca, NY, USA) placed just above the aortic cannula. The electrical activity of the heart preparations was assessed from the volume-conducted ECG as well as monophasic action potential recordings. Throughout the experiments, the heart preparations were kept immersed in the temperature-controlled, perfusate-filled chamber to minimize thermal loss. Aortic pressure, coronary flow rate, ECG and ventricular action potentials were continuously monitored using the 16-channel PowerLab system (ADInstruments, Oxford, UK).
Monophasic action potentials, refractory periods, and electrical stimulations
In order to slow the intrinsic beating rate and enable ventricular stimulations at variable pacing intervals, both atria were removed and the atrioventricular node was crushed mechanically with forceps prior to making electrophysiological recordings. Epicardial monophasic action potentials (MAPs) were obtained from the base of the LV and the RV lateral wall using spring-loaded pressure contact electrodes (Hugo Sachs Electronik/Harvard Apparatus GmbH). The action potential duration was measured at 90% repolarization (APD 90 ). For electrical stimulations, the bipolar needle electrodes were placed at the LV epicardium close (within 3-4 mm) to the adjacent MAP recording electrode. The stimulations were performed with 2 ms rectangular pulses generated by a programmable stimulator (Hugo Sachs Electronik/Harvard Apparatus GmbH). In addition to LV stimulations utilized in the main part of the study, in a subset of experiments, the electrical stimulations were applied at RV epicardium, close to the RV MAP recording electrode.
The programmed stimulation protocol involved an application of the burst of 10 regular (S 1 ) pulses followed by a premature extrastimulus (S 2 ) generated at progressively reduced coupling intervals (S 1 -S 2 ). In successive stimulations, the S 1 -S 2 interval was reduced from 500 to 200 ms in steps of 100 ms, followed by further 5-10 ms decrements until the refractoriness was reached. The longest S 1 -S 2 interval that failed to produce ventricular capture was normalized by subtracting the activation latency in the S 1 beat and taken as the effective refractory period (ERP). In parallel, the functional refractory period was determined as the shortest ventricular response interval (V 1 -V 2 ) attained upon progressive reduction of the S 1 -S 2 interval (Liem et al., 1988) . The V 1 -V 2 interval was measured as the time between the action potential upstroke in the last S 1 beat in a drive train and the upstroke of the following S 2 -evoked action potential, both at LV and RV MAP recording sites.
Ventricular conduction
Ventricular conduction intervals were assessed in the last S 1 beat in a basic drive train and in premature beats upon extrastimulus application, as illustrated in Figure 1 . The activation latency at the LV stimulation site was measured as the time from the pacing stimulus artifact to the fastest upstroke of the following action potential. The LV-to-RV conduction delay was determined as the delay between the upstrokes of the LV action potential and the RV action potential. The total conduction time was calculated as a sum of the activation latency and the LV-to-RV delay. The minimal ventricular capture interval (e.g. the S 1 -S 2 interval applied in the second beat in Figure 1 ) is referred to throughout the text as the S 1 -S 2 coupling stimulation interval exceeding the ERP by 5 ms.
Study groups
The main data were obtained from three series of experiments in which the electrical stimulation protocol was applied at LV epicardium. In the first series (n = 9), ventricular APD 90 , refractory periods, and the S 2 vs. S 1 conduction intervals were measured upon variations in parameters of programmed stimulations, namely, the basic drive train cycle length (550 vs. 300 ms) and the stimulating current intensity (2 times vs. 5 times diastolic threshold). The second series (n = 11) examined effects produced by hypokalaemic (2.5 mM KCl) vs. normokalaemic perfusion (4.7 mM KCl). These levels of hypokalaemia (2.5 mM KCl) have been shown to produce significant effects on ventricular repolarization and conduction in perfused guinea-pig heart in previous studies (Osadchii, 2014a; Osadchii, Bentzen, & Olesen, 2009) Representative monophasic action potentials from the left ventricular (LV, upper trace) and the right ventricular (RV, lower trace) epicardium were recorded during S 1 -S 2 stimulations applied in the LV chamber. Conduction intervals were assessed in the last regular (S 1 ) beat in a drive train, and in a premature beat upon an application of extrastimulus (S 2 ). The activation latencies in the regular beat (L 1 ) and in the premature beat (L 2 ) were measured from the moment of S 1 and S 2 application, respectively, to the fastest upstroke of the following action potential (vertical dotted line). The LV-to-RV conduction delays in the regular beat (D 1 ) and in the premature beat (D 2 ) correspond to the delays between the upstrokes of the LV action potential and the RV action potential upon S 1 and S 2 application, respectively. The total conduction time in the regular beat (CT 1 ) is the sum of L 1 and D 1 , and the total conduction time in the premature beat (CT 2 ) is the sum of L 2 and D 2 . Note that S 2 application at the shortest coupling interval that allows ventricular capture is associated with markedly increased activation latency (L 2 is greater than L 1 ), but no significant change in the LV-to-RV delay (D 2 is similar to D 1 ), compared to the values determined in the S 1 beat. in conditions of basal normokalaemic perfusion during LV stimulations were compared to those obtained with RV stimulations. An overview of the experimental series and the programmed stimulation protocols used is given in Table 1 .
Drug adminisrration
Flecainide (Sigma-Aldrich, Taufkirchen, Germany) was infused at a concentration of 1.5 M, which is close to the maximum free (i.e. protein-unbound) therapeutic plasma levels (Conard & Ober, 1984 ).
For precise dosing, drug infusions were performed at a rate of 0.3 ml min −1 using a calibrated infusion pump, while perfusing the hearts with normokalaemic saline solution at a constant coronary flow rate (see above).
TA B L E 1
An overview of experimental series and the programmed stimulation protocols used in the study 
Data analysis
The data were analysed using Chart 5 Pro for Windows software (ADInstruments). Data are expressed as mean ± standard deviation.
One-way ANOVA followed by the Tukey-Kramer test was used for multiple comparisons, and Student's paired t tests was used to compare two data sets. P values less than 0.05 were considered to be significant. At the shortest S 1 -S 2 interval that enabled LV capture (S 1 -S 2 of 172 ± 8 ms), the total conduction time of the S 2 beat was increased by 30% compared to its value during S 1 pacing. This increase was almost entirely accounted for by the markedly prolonged activation latency at the LV stimulation site (Figure 2a) , whereas the LV-to-RV delay showed only negligible changes (Figure 2b) . Specifically, at the minimal ventricular capture interval, the activation latency was increased by 54%, whilst an increment in LV-to-RV delay amounted to only 12%, compared to the values determined for the S 1 beat (Figure 2d ).
RESULTS
Ventricular conduction intervals in S 2 vs. S 1 beats during programmed stimulations
In a subset of experiments, ventricular conduction intervals determined upon LV stimulations were compared to those obtained when the stimulation protocol was applied at the RV epicardium (Figure 3) . At the shortest S 1 -S 2 interval that enabled RV capture (S 1 -S 2 of 171 ± 6 ms), the percentage increase in the activation latency in the S 2 vs. S 1 beat (+61%) was much greater compared to the increment in RV-to-LV delay (+11%), thus replicating the relationships observed (a-c) During programmed stimulations, the LV activation latency (a), LV-to-RV delay (b) and total conduction time (c) were measured upon progressive shortening of the S 1 -S 2 interval towards the minimal values slightly exceeding the effective refractory period (ERP, the vertical dashed line). R denotes the values of conduction intervals measured in the last regular beat in a drive train prior to extrastimulus application. (d) Percentage increase in LV activation latency and LV-to-RV delay in S 2 beats evoked at the shortest ventricular capture interval, compared to the values determined in the S 1 beats. * P < 0.05.
V 1 -V 2 to S 1 -S 2 relations
A prolongation of ventricular conduction upon extrastimulus application may be acting to limit the value of the functional response interval in cardiac cells. In Figure 4 , these effects are addressed by plotting the V 1 -V 2 response intervals obtained during programmed LV stimulations as a function of the S 1 -S 2 interval.
The measurements illustrated in Figure 4a suggest that the V 1 -V 2 interval (i.e. the time between the upstrokes of S 1 -and S 2 -induced action potentials) at the LV site would be equal to the S 1 -S 2 interval if the activation latency is the same in the S 2 vs.
Likewise, the RV response interval is equal to the S 1 -S 2 interval if the LV-to-RV delay is the same in the S 2 vs. S 1 beat (i.e. D 1 = D 2 ). Figure 4b shows that these relations are valid when an extrastimulus is applied at the long S 1 -S 2 intervals. Indeed, with S 1 -S 2 ranging from 550 to 200 ms, the V 1 -V 2 responses in both the LV and the RV chamber fall on the identity line, indicating that any reduction in the S 1 -S 2 interval is followed by a proportional decrease in V 1 -V 2 response interval. This is explained by no change in either the activation latency or the LV-to-RV delay in S 2 vs. S 1 beats when an extrastimulus is applied in late diastole (Figure 2a,b) . Nevertheless, the V 1 -V 2 vs. Figure 6 shows effects of varying stimulus intensity on the outcomes of programmed LV stimulations applied at S 1 -S 1 = 550 ms. An increase in the stimulating current strength from 2 to 5 times diastolic threshold had no effect on LV APD 90 , but decreased the ERP in the S 1 beat, leading to the reduced ERP-to-APD 90 ratio (Figure 6a,d,g ). In the S 1 beat, the activation latency at the LV stimulation site was reduced when using a higher stimulus intensity (Figure 6b ). The reduced ERPto-APD 90 ratio allowed the S 2 capture to occur earlier during the repolarization phase (77% vs. 87% repolarization time with 5 times vs. 2 times diastolic threshold, respectively). The increased S 2 prematurity contributed to the prolonged activation latency in S 2 beats (Figure 6b ), resulting in markedly accentuated percentage increase in the activation latency in S 2 vs. S 1 beats (Figure 6c ), when using a higher stimulus intensity. The S 2 vs. S 1 changes in the total conduction time (Figure 6h ,i) followed those in the activation latency (Figure 6b,c ).
S 1 -S 2 stimulating current strength
An increase in the stimulating current strength, however, had no effect on the LV-to-RV delay either in the S 1 or S 2 beat (Figure 6e ), or its percentage increment upon premature ventricular activation (Figure 6f ). S 1 beats (Figure 7c ). The LV-to-RV delay in hypokalaemic hearts was 
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Effects of flecainide
DISCUSSION
Main findings
This study suggests that during programmed stimulations, independently of the S 1 -S 1 cycle length used, slowed conduction in premature beats initiated shortly after the termination of ERP is primarily accounted for by the markedly increased activation latency at the LV stimulation site, with only negligible changes occurring in LV-to-RV delay. Increased activation latency is acting to limit the minimal ventricular response intervals in the LV and RV chambers. The prolongation of the activation latency in premature beats is further accentuated upon interventions (such as an increase in the stimulating current intensity, or hypokalaemia) that reduce the ERP-to-APD 90 ratio, and hence permit extrastimulus capture earlier during phase 3
repolarization. The Na + channel blocker flecainide prolongs both the activation latency and the LV-to-RV delay in the regular and premature beats, without changing their relative contributions into the increment in total conduction time in S 2 vs. S 1 beats.
Changes in the activation latency in S 2 vs. S 1 beats
An extrastimulus applied in late diastole, i.e. when excitability is fully recovered in cardiac cells, initiates an action potential with a fast upstroke which rapidly propagates from the stimulation site to the adjacent MAP recording site in the LV chamber. This accounts
LV ERP, ms
Activation latency, ms S1-S1=550 ms S1-S1=300 ms S 1 -S 1 =550 ms S1-S1=300 ms S1-S1=550 ms for only a brief (about 12 ms) activation latency. In contrast, an extrastimulus applied at the shorter S 1 -S 2 intervals close to ERP, i.e.
prior to the completion of repolarization and full recovery of Na + channels from inactivation, typically initiates a slowly rising action potential (Ramza et al., 1990) , or even a graded response (subthreshold depolarization) which can propagate a few millimetres away from the stimulation site and induce a regenerative activation in the distal cells with recovered excitability (Gotoh et al., 1997; Hoffman, Kao, & Suckling, 1957; Karagueuzian & Chen, 2001) . As both slowly rising action potentials and graded responses are associated with decreased conduction velocity, the activation latency is markedly prolonged in S 2 beats.
These changes are amplified upon decreasing the takeoff potential for initiation of the premature ventricular responses, consistent with progressively reduced Na + channel availability at incomplete repolarization levels (Weidmann, 1955) . Accordingly, the prolongation of the activation latency in S 2 beats is accentuated upon interventions that decrease the ERP-to-APD 90 ratio and therefore allow the ventricular capture to occur at the earlier repolarization time points; in the present study, this was observed with increasing the S 1 -S 2 stimulating current intensity, or upon hypokalaemic perfusion. With hypokalaemia, the contributing mechanism appears to be related to the contrasting changes in APD 90 vs. ERP, that is, whilst APD 90 is prolonged, presumably through inhibition of I Kr , the rapid component of the delayed rectifier K + current (Sanguinetti & Jurkiewicz, 1992) , the ERP is shortened, most likely owing to the hypokalaemia effects on the recovery of Na + channels from inactivation in final repolarization phase (Kern, El-Berins, & Volbehr, 1978; Li, Zeng, Zhuang, & Liu, 1992) . With increased stimulating current strength, a reduction in ERP is attributable to the increased number of depolarized myocytes upon extrastimulus application, and therefore improved source-to-sink ratio (Kleber & Rudy, 2004) , which facilitates initiation of the propagated responses at less complete repolarization levels. With flecainide, a class Ic Na + channel blocker, changes in the activation latency in premature beats are likely to be determined by an interplay of several factors. Whilst flecainide can moderately prolong APD 90 owing to its inhibitory effect on I Kr (Melgari, Zhang, El Harchi, Dempsey, & Hancox, 2015; Wang, Kiyosue, Sato, & Arita, 1996) , it produces more prominent ERP lengthening in connection with its I Na blocking effects, which leads to the increased ERP-to-APD 90 ratio. The latter postpones the initiation of the earliest S 2 response towards a later repolarization time point, an effect that can be expected to prevent a prolongation of the activation latency in S 2 vs. S 1 beats, assuming a greater Na + channel availability at more negative membrane potentials (Weidmann, 1955) . This voltagedependent change, nevertheless, is balanced by the drug-induced I Na block, which leads to the reduced number of Na + channels recovered from inactivation at a given level of the membrane potential throughout the repolarization phase (Glaaser & Clancy, 2006) . As a result, flecainide effects during programmed stimulations appear to be mostly related to the increase in the S 1 -S 2 interval at which the activation latency starts to be prolonged upon S 2 applications with increasing proximity to a preceding action potential, whereas the magnitude of the S 2 vs. S 1 increment in the activation latency is not significantly changed (Figure 8c ).
Changes in the LV-to-RV delay in S 2 vs. S 1 beats
The velocity of the action potential upstroke (V max ) is thought to be the primary determinant of the conduction time in premature ventricular beats (Ramza et al., 1990; Weidmann, 1955) . When a premature activation is initiated in incompletely repolarized cells prior to the full recovery of Na + channels, the V max is reduced and the conduction is slowed. The present study, nevertheless, suggests that these changes are minimized in the setting of the prolonged activation latency. An increase in the activation latency ensures that cellular repolarization can proceed for 18-20 ms after the extrastimulus application, until it is interrupted by a premature action potential (Figures 1 and 2a) . As the moment for initiation of the premature activation is postponed towards a later repolarization time point whereby more Na + channels have recovered from inactivation, the expected V max reduction in the S 2 beat is minimized, which translates to only marginal (+12%, Figure 2d ) increase in the LV-to-RV delay, compared to its value in the regular beat.
Ventricular conduction is known to be slowed upon drug-induced attributable to the suppression of I K1 , the inward rectifier K + current (Weiss, Qu, & Shivkumar, 2017) . In this study, even though hypokalaemia and flecainide were found to significantly increase the LV-to-RV delay in both S 1 and S 2 beats (Figures 7e and 8e) , the percentage increment in the LV-to-RV delay in S 2 vs. S 1 beats remained the same (Figures 7f and 8f) . The latter can be partly explained by a prolongation of the activation latency in S 2 beats in both settings (Figures 7b and 8b) , with a subsequent effect on timing of the premature activation in the late repolarization phase.
Overall, the aforementioned changes imply that an increase in the activation latency upon premature ventricular activation may represent an intrinsic regulation that prevents a significant slowing of the conduction velocity with which the initiated depolarization wave spreads away from the stimulation site.
Clinical implications
The conventional clinical electrophysiological techniques do not allow us to discriminate whether conduction slowing upon premature activation is attributable to the prolonged activation latency, or slowed impulse propagation away from the stimulation site, or both. The endocardial electrogram recordings performed during electrophysiological testing are invariably limited to the RV chamber (Koller et al., 1995a; Liem et al., 1988; Mitchell et al., 1986; Wellens et al., 1985) , and hence do not permit the evaluation of the interventricular conduction delay. The monophasic action potential recordings in cardiac patients are technically complicated and therefore not used in daily clinical work. With other techniques, for example the pace mapping which is designed to locate the arrhythmia source by pacing at multiple endocardial sites, ventricular conduction time is assessed by measuring the interval between the pacing stimulus artifact and the onset of the QRS complex on the surface ECG (Brunckhorst et al., 2003) . Although this can provide a crude measure of slow conduction, the contributing physiological factors remain uncertain. In this regard, the present study suggests that a significant part of the large-scale conduction delay measured during clinical testing may be related to the increased activation latency at the stimulation site, rather than conduction slowing away from it, at least during premature activations initiated during phase 3 repolarization.
Another practical aspect of this study is related to the impact of the less responsive to antiarrhythmic drugs (Chen et al., 2003; Opthof et al., 1991; Wu, Lin, Weiss, Ting, & Chen, 2002) . However, with interventions that prolong the activation latency in S 2 beats (e.g.
hypokalaemia or increased stimulating current intensity), the ERP reduction is likely to be associated with no change in the minimal ventricular response interval (i.e. the functional refractory period), thus eliminating the possibility of accelerated excitation frequency.
These relationships, therefore, challenge the value of assessments aimed at predicting the activation frequency during tachyarrhythmia based on measuring the ERP alone.
Impact of hypokalaemia and flecainide
Importantly, cardiac electrophysiological changes produced by hypokalaemia or flecainide are likely to be of clinical relevance.
Indeed, hypokalaemia represents the most common electrolyte disorder seen in cardiac patients, and typically develops as a side effect of diuretic therapy, or may be caused by neurohormonal derangements in heart failure (Weiss et al., 2017) . Hypokalaemia occurs in about 16% of patients admitted to hospital (Jensen, Brabrand, Vinholt, Hallas, & Lassen, 2015) , and it plays an important role in cardiac arrhythmogenesis by facilitating the arrhythmic triggers, such as the early and delayed afterdepolarizations, and by causing conduction slowing and repolarization derangements, which precipitate re-entry (Weiss et al., 2017) . With flecainide, an increase in the risk of arrhythmic death has been found in patients with healed myocardial infarction enrolled in the CAST trial (CAST Investigators, 1989) . The flecainide-induced arrhythmia is thought to be attributable to multiple mechanisms, including nonuniform conduction slowing in myocardial regions bordering the post-infarction scar (Ranger & Nattel, 1995) and amplified spatial repolarization gradients (Osadchii, 2014b) . Flecainide, nevertheless, remains one of the first line treatments used for the rhythm control in atrial fibrillation in patients with structurally normal hearts (Apostolakis et al., 2013) . This agent is also considered to be a promising treatment option in patients with catecholaminergic polymorphic ventricular tachycardia (Salvage et al., 2018) . Overall, these clinical findings, in connection with the results of the present study, strongly suggest that both hypokalaemia and flecainide treatment should be considered among those factors which can influence the outcome of ventricular conduction assessments and associated arrhythmogenicity during programmed stimulations in cardiac patients.
Activation latency in the premature beats: the contributing mechanisms
The activation latency measured at the LV stimulation site has a complex mechanism, and includes both the time needed to initiate the action potential and the time taken for the action potential to propagate from the stimulating electrodes to the adjacent MAP recording electrodes. Importantly, the S 2 application is known to produce a greater conduction slowing close to the pacing site than in distant myocardial regions (Karagueuzian & Chen, 2001; Koller et al., 1995a, b) , an effect that can be partly attributed to the impaired source-sink relationships (Kleber & Rudy, 2004) . With point stimulation, the number of depolarized cells (i.e. the source) is small and the initiated depolarization wavefront is very convex, which contributes to the dissipation of the excitatory current over a large downstream myocardial area (i.e. the sink). The resulting source-sink mismatch then may account for the low conduction velocity with which the impulse spreads away from the pacing site. Upon subsequent ventricular activation, the area of depolarized cells is progressively increased, and the wavefront curvature is reduced, thus improving the source-sink ratio, and reducing the degree of conduction slowing at the distant sites. With these considerations, it can be assumed that upon S 2 application in late diastole, a significant part of the activation latency is attributable to the local conduction slowing in the immediate vicinity of the stimulating electrode, rather than to the time needed to initiate a premature action potential. These relations, nevertheless, can be significantly changed upon S 2 application during phase 3 repolarization (i.e. in close proximity to ERP) in the preceding S 1 beat (Figure 1 ). In the setting of the reduced Na + channel availability in incompletely repolarized cardiac cells (Weidmann, 1955) , the S 2 application evokes a depolarizing graded response that slowly attains the threshold voltage for generating an action potential upstroke (Gotoh et al., 1997; Hoffman et al., 1957; Karagueuzian & Chen, 2001 ).
Consequently, the initiation of the propagating action potential is significantly delayed. Therefore, when S 2 is applied shortly after the termination of ERP, the prolonged time for initiation of the premature action potential is likely to be an independent factor that contributes to the activation latency at the stimulation site.
Limitations
In this study, action potential recordings were performed at only two sites in the LV and RV epicardium, thus providing no information on the pathway of electrical activation during programmed stimulation, and precluding the assessments of the conduction velocity. Spatiotemporal mapping studies that involve optical action potential recordings at multiple ventricular sites are warranted in order to assess more precisely the relative contribution of the activation latency at the stimulation site and the LV-to-RV delay to the mechanism of conduction slowing in premature beats.
Conclusions
During cardiac electrophysiological testing, prolonged activation latency at the stimulation site should be considered as the critical determinant of conduction slowing and associated changes in the ventricular response intervals in premature beats initiated shortly after the termination of the effective refractory period.
